New hope for tough ovarian cancers: testing a powerful drug duo
Disease control
Recruiting now
This study is testing a new combination of two drugs, vismodegib and atezolizumab, for women with ovarian, fallopian tube, or primary peritoneal cancer that has become resistant to platinum-based chemotherapy. The goal is to see if this drug pair can shrink tumors and control the…
Phase: PHASE2 • Sponsor: Ronald Buckanovich • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC